Johannes Raffler
Overview
Explore the profile of Johannes Raffler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
2235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manz R, Backer J, Cramer S, Meyer P, Muller D, Muzalyova A, et al.
J Pathol Clin Res
. 2025 Mar;
11(2):e70023.
PMID: 40079401
This work aimed to evaluate both the usefulness and user acceptance of five gradient-based explainable artificial intelligence (XAI) methods in the use case of a prostate carcinoma clinical decision support...
2.
Muller D, Meyer P, Rentschler L, Manz R, Hieber D, Backer J, et al.
Stud Health Technol Inform
. 2024 Aug;
316:1110-1114.
PMID: 39176576
Prostate cancer is a dominant health concern calling for advanced diagnostic tools. Utilizing digital pathology and artificial intelligence, this study explores the potential of 11 deep neural network architectures for...
3.
Weinisch P, Raffler J, Romisch-Margl W, Arnold M, Mohney R, Rist M, et al.
Cell Rep
. 2024 Jul;
43(8):114416.
PMID: 39033506
Metabolism oscillates between catabolic and anabolic states depending on food intake, exercise, or stresses that change a multitude of metabolic pathways simultaneously. We present the HuMet Repository for exploring dynamic...
4.
Weinisch P, Raffler J, Romisch-Margl W, Arnold M, Mohney R, Rist M, et al.
bioRxiv
. 2023 Aug;
PMID: 37609175
The human metabolism constantly responds to stimuli such as food intake, fasting, exercise, and stress, triggering adaptive biochemical processes across multiple metabolic pathways. To understand the role of these processes...
5.
Huss R, Raffler J, Markl B
Cancer Rep (Hoboken)
. 2023 Feb;
6(7):e1796.
PMID: 36813293
Background: The currently available immunotherapies already changed the strategy how many cancers are treated from first to last line. Understanding even the most complex heterogeneity in tumor tissue and mapping...
6.
Surendran P, Stewart I, Au Yeung V, Pietzner M, Raffler J, Worheide M, et al.
Nat Med
. 2022 Nov;
28(11):2321-2332.
PMID: 36357675
Garrod's concept of 'chemical individuality' has contributed to comprehension of the molecular origins of human diseases. Untargeted high-throughput metabolomic technologies provide an in-depth snapshot of human metabolism at scale. We...
7.
Weinisch P, Fiamoncini J, Schranner D, Raffler J, Skurk T, Rist M, et al.
Front Nutr
. 2022 Oct;
9:933526.
PMID: 36211489
Food intake triggers extensive changes in the blood metabolome. The kinetics of these changes depend on meal composition and on intrinsic, health-related characteristics of each individual, making the assessment of...
8.
Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, Worheide M, et al.
Science
. 2021 Oct;
374(6569):eabj1541.
PMID: 34648354
Characterization of the genetic regulation of proteins is essential for understanding disease etiology and developing therapies. We identified 10,674 genetic associations for 3892 plasma proteins to create a cis-anchored gene-protein-disease...
9.
Zacharias H, Altenbuchinger M, Schultheiss U, Raffler J, Kotsis F, Ghasemi S, et al.
Am J Kidney Dis
. 2021 Jul;
79(2):217-230.e1.
PMID: 34298143
Rationale & Objective: Stratification of chronic kidney disease (CKD) patients at risk for progressing to kidney failure requiring kidney replacement therapy (KFRT) is important for clinical decision-making and trial enrollment....
10.
Pietzner M, Stewart I, Raffler J, Khaw K, Michelotti G, Kastenmuller G, et al.
Nat Med
. 2021 Mar;
27(3):471-479.
PMID: 33707775
Multimorbidity, the simultaneous presence of multiple chronic conditions, is an increasing global health problem and research into its determinants is of high priority. We used baseline untargeted plasma metabolomics profiling...